GGrantIndex
Sort

51,593 grants matching hepatitis

HCV Entry: Mechanisms and Therapeutics

$597,258
Tianyi Wang · Sri International · R01 · FY2017 · DK

CVD in American Indians Genetics Center

$597,222
Shelley A Cole · Texas Biomedical Research Institute · R01 · FY2016 · HL

CVD in American Indians Genetics Center

$597,222
Shelley A Cole · Texas Biomedical Research Institute · R01 · FY2017 · HL

Exploring respiratory chain glycoproteomics in mitochondrial disease

$597,187
Marni J Falk · Children'S Hosp Of Philadelphia · R01 · FY2016 · GM

Animal and Biostatistics Core

$597,112
Todd E Morgan · University Of Southern California · P01 · FY2018 · AG

Role of extracellular vesicles in the regulation of immunometabolism in obesity

$597,009
Takahisa Nakamura · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · DK

Hepatitis Beta Research Network Clinical Center in Pacific Northwest/Alaska

$596,988
Robert L Carithers · University Of Washington · U01 · FY2013 · DK

Adjuvanted Epitope Vaccine to Target HIV Reservoirs

$596,881
University Of Pittsburgh At Pittsburgh · R01 · FY2005 · AI

Adiponectin in Cardiovascular Biology and Pathology

$596,865
Harvey F Lodish · Massachusetts Institute Of Technology · P01 · FY2008 · HL

Preclinical studies of a heroin/morphine vaccine for opiate addiction

$596,812
Paul Pentel · Hennepin Healthcare Research Institute · R01 · FY2012 · DA

Multi-level Evaluation of Racial/ethnic Disparities in Liver Disease Outcomes

$596,725
Fasiha Kanwal · Baylor College Of Medicine · R01 · FY2023 · CA

CBPR on Hepatitis B Intervention for Underserved Korean Americans

$596,678
Grace X Ma · Temple Univ Of The Commonwealth · R24 · FY2009 · MD

Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing

$596,655
Charles Yen Chiu · University Of California, San Francisco · R01 · FY2011 · HL

Opioids & HIV Medications: Interactions in Drug Abusers

$596,602
Elinore F. McCance-Katz · University Of California, San Francisco · R01 · FY2007 · DA

Animal and Biostatistics Core

$596,557
Todd E Morgan · University Of Southern California · P01 · FY2019 · AG

Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention

$596,545
Joshua T Herbeck · University Of Washington · R01 · FY2020 · DA

Hepatitis C virus genome structure: dynamic roles in replication and infectivity

$596,514
Anna Marie Pyle · Yale University · R01 · FY2018 · AI

Integration of Systems and Synthetic Biology to Advance Development of Human Tissues In Vitro

$596,431
Mo Reza Ebrahimkhani · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK

ESOPHAGEAL VARICES BY B-ADRENERGIC BLOCKERS

$596,414
Yale University · R01 · FY2000 · DK

Novel Transgenic Rabbit Model for Cardiovascular Disease

$596,411
Fuliang Du · Evergen Biotechnologies, Inc. · R44 · FY2008 · HL

Epigenetic Mechanisms Underlying Hepatitis C-Induced Hepatocarcinogenesis

$596,382
Keith D Robertson · Mayo Clinic Rochester · R01 · FY2020 · DK

Epigenetic Mechanisms Underlying Hepatitis C-Induced Hepatocarcinogenesis

$596,382
Keith D Robertson · Mayo Clinic Rochester · R01 · FY2019 · DK

Regulation of Hepatic Lipid and Glucose Metabolism by PC-TP/StarD2

$596,301
David E Cohen · Weill Medical Coll Of Cornell Univ · R37 · FY2018 · DK

Regulation of Hepatic Lipid and Glucose Metabolism by PC-TP/StarD2

$596,301
David E Cohen · Weill Medical Coll Of Cornell Univ · R37 · FY2020 · DK

Regulation of Hepatic Lipid and Glucose Metabolism by PC-TP/StarD2

$596,301
David E Cohen · Weill Medical Coll Of Cornell Univ · R37 · FY2019 · DK